TO THE POINT
  • 25 years of experience
  • BS in Biology
  • MD from Yale University School of Medicine
  • Professor for the Department of Neurosurgery, Division of Surgery at the University of Texas MD Anderson Cancer Center
  • Director of Clinical Research Department of Neurosurgery, Division of Surgery at the University of Texas MD Anderson Cancer Center
  • Adjunct Professor for the Department of Neurosurgery at Baylor College of Medicine
  • Recipient of America’s Top Doctors for Cancer
  • Recipient of the Preuss Research Award
  • Recipient of the Mahaley Award
  • Recipient of the Michael S. Voynick Award in Neuro-Oncology
  • Executive Committee of the American Association of Neurological Surgeons
  • Has published more than 150 peer-reviewed articles and book chapters

Frederick F. Lang Jr., MD, FACS,
FAANS

Boardmember

Dr. Lang is a leader in the field of neurosurgery with particular focus on deep seated brain tumors located in eloquent brain regions. Currently Dr. Lang is a tenured professor for the Department of Neurosurgery, Division of Surgery at the University of Texas MD Anderson Cancer Center (UTMDACC) in Houston. He also serves as Director of Clinical Research at the Center. Dr. Lang is a faculty member at UTMDACC’s Graduate School of Biomedical Sciences and an Adjunct Professor for the Department of Neurosurgery at Baylor College of Medicine.

Dr. Lang earned a BS in Biology at Yale and received his MD from Yale University School of Medicine. He went on to complete his residency in neurosurgery at New York University Medical Center as well as a fellowship in neurosurgical oncology at UTMDACC.  Dr. Lang is the recipient of numerous awards and honors including America’s Top Doctors for Cancer, Guide to America’s Top Surgeons, the Preuss Research Award, the Mahaley Award, and the Michael S. Voynick Award in Neuro-Oncology. He is a NIH-funded translational researcher who has published extensively on gene, viral and cellular therapies for brain tumors and is Principal Investigator on multiple clinical trials that investigate these new approaches. He has served on the Executive Committee of the American Association of Neurological Surgeons’ CNS Section on Tumors and is the past Chair of this section.

Dr. Lang is a past president and current boardmember of the Board of Directors of the Society for Neuro-Oncology. He is board certified in neurosurgery and is a Fellow of the American College of Surgeons and the American Association of Neurological Surgeons. Dr. Lang is an Associate Editor of Neurosurgery and on the Editorial Board of Neuro-Oncology and Translational Oncology. He served on the Developmental Therapeutic Study Section within the NIH until his tenure ended in 2011, He has continued as an ad hoc reviewer for NIH and is frequently requested as a national and international lecturer. He has published more than 150 peer-reviewed articles and book chapters.